Paula Wasserman

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

Ralf Reilmann, Andrew McGarry, Igor D. Grachev et al. · The Lancet Neurology · 2018 · 104 citations

Neurodegenerative Diseases, Medicine, Psychotropic Medication +6

Quantifying Postural Control in Premanifest and Manifest Huntington Disease Using Wearable Sensors

Franchino Porciuncula, Paula Wasserman, Karen Marder et al. · Neurorehabilitation and neural repair · 2020 · 27 citations · Full text

Longitudinal Change in Gait and Motor Function in Pre-manifest Huntington’s Disease

Ashwini K. Rao, Pietro Mazzoni, Paula Wasserman et al. · PLoS Currents · 2011 · 25 citations · Full text

Gait Analysis, Physical Activity, Neuromuscular Coordination +27

Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease

Nicole Lewandowski, Yvette Bordelon, Adam M. Brickman et al. · Neurobiology of Disease · 2012 · 24 citations · Full text

Neuroimaging Biomarkers, Genetics, Fmri-guided Molecular Analysis +8

Acoustic Analysis of Voice and Speech Characteristics in Presymptomatic Gene Carriers of Huntington's Disease: Biomarkers for Preclinical Sign Onset?

Lea R. Kaploun, John H. Saxman, Paula Wasserman et al. · NSUWorks (Nova Southeastern University) · 2011 · 13 citations

Health Sciences, Genetics, Pathological Speech +10